sphingosin
type
receptor
express
lymphocyt
regul
immun
cell
traffick
sphingosin
analogu
caus
intern
degrad
receptor
prevent
auto
reactiv
immun
cell
target
tissu
shown
receptor
agonist
fingolimod
suitabl
candid
treatment
autoimmun
diseas
current
studi
aim
gener
grindbas
predict
model
agonist
activ
deriv
use
virtual
screen
chemic
librari
develop
model
receptor
agonist
show
appropri
power
predict
intern
r
acc
sdec
extern
r
mae
data
valid
gener
model
reveal
import
variabl
dryo
potenc
select
compound
toward
receptor
propos
potenti
chemic
entiti
agonist
activ
pubchem
chemic
databas
search
select
compound
virtual
test
receptor
agonist
activ
use
gener
model
result
four
potenti
compound
high
potenc
select
toward
receptor
moreov
affin
identifi
compound
toward
receptor
evalu
use
molecular
dynam
simul
result
indic
bind
energi
compound
rang
kcal
mol
calcul
mmgbsa
mmpbsa
algorithm
respect
find
current
work
may
use
identif
potent
select
receptor
agonist
potenti
use
diseas
multipl
sclerosi
sphingosin
bioactiv
signal
molecul
lysophospholipid
lpl
involv
differ
cellular
action
vascular
growth
develop
regul
immun
cell
morphogenesi
arrang
cytoskeleton
lipid
particular
aminoalcohol
structur
known
sphingosin
bind
receptor
receptor
g
proteincoupl
receptor
gpcr
ntermin
protein
form
amphipath
bind
pocket
craft
helic
cap
hinder
ligand
access
bind
pocket
howev
believ
lpl
attain
bind
site
cell
membran
instead
extracellular
region
receptor
express
lymphocyt
regul
immun
cell
ieband
tcell
traffick
gradient
concentr
blood
interstiti
fluid
lymph
control
egress
lymphocyt
analogu
caus
intern
degrad
receptor
sustain
activ
receptor
prevent
auto
reactiv
immun
cell
target
tissu
divers
structur
moieti
demonstr
receptor
agonist
effect
potenti
candid
use
treatment
autoimmun
diseas
fingolimod
receptor
modul
approv
relaps
form
multipl
sclerosi
ms
autoimmun
disord
affect
central
nervou
system
convers
phosphat
form
fingolimod
activ
receptor
although
exact
role
receptor
remain
unclear
advers
effect
fingolimod
attribut
activ
receptor
therefor
differ
studi
sever
select
receptor
agonist
synthes
order
retain
therapeut
properti
receptor
agonist
minimum
side
effect
nowaday
threedimension
quantit
structureact
relationship
method
base
molecular
interact
field
mif
approach
accept
standard
tool
medicin
chemistri
drug
design
howev
rate
limit
step
studi
obtain
appropri
ligand
align
gridindepend
descriptor
grind
offer
altern
approach
analys
align
ligand
requir
instead
product
interact
energi
pair
mif
use
build
model
sever
exampl
success
applic
alignmentindepend
method
use
grind
descriptor
result
compar
grid
base
alignmentdepend
studi
bolli
et
al
synthes
seri
deriv
investig
agonist
effect
receptor
among
synthes
deriv
compound
demonstr
highest
receptor
agonist
activ
minimum
agon
therefor
compound
current
known
ponesomid
select
vivo
studi
could
significantli
reduc
circul
lymphocyt
rat
current
studi
aim
gener
grindbas
predict
model
agonist
activ
deriv
receptor
order
identifi
structur
featur
relev
select
activ
receptor
identifi
structur
featur
consist
develop
model
use
search
pubchem
small
molecul
databas
select
compound
select
receptor
agonist
activ
current
work
set
receptor
agonist
synthes
base
scaffold
select
literatur
studi
tabl
activ
express
ec
assess
use
membran
prepar
cho
cell
express
recombin
human
receptor
valu
convert
pec
use
depend
variabl
studi
hyperchem
softwar
version
employ
gener
structur
ligand
mm
forc
field
base
polackribier
algorithm
use
energi
minim
structur
optim
semiempir
approach
algorithm
crystal
structur
model
structur
receptor
use
dock
calcul
crystal
structur
receptor
complex
antagonist
retriev
protein
data
bank
pdb
code
model
gener
use
homolog
model
swiss
model
web
server
base
receptor
structur
pdb
code
templat
qualiti
geometr
featur
obtain
model
check
use
procheck
molprob
program
coordin
antagonist
complex
receptor
use
dock
studi
ligand
receptor
crystal
structur
use
gold
program
version
ccdc
cambridg
uk
run
linux
oper
system
determin
ligand
bind
site
model
receptor
structur
align
receptorantagonist
complex
new
merg
complex
built
consist
receptor
antagonist
final
posit
antagonist
new
complex
use
guid
determin
bind
site
dock
calcul
chemplp
score
function
gold
program
use
dock
calcul
dock
experiment
cocrystal
antagonist
bind
site
receptor
result
solut
rmsd
experiment
observ
posit
therefor
dock
score
function
use
best
activ
conform
activ
compound
data
set
ie
compound
receptor
respect
select
base
dock
score
best
conform
rest
compound
select
base
maximum
shape
similar
activ
compound
ie
compound
receptor
respect
use
tanimoto
algorithm
implement
shapeit
program
obtain
activ
conform
introduc
pentacl
program
produc
grindbas
descriptor
initi
molecular
interact
field
mif
gener
use
grid
base
field
calcul
interact
energi
grid
point
call
node
compound
atom
differ
probe
includ
hydrophob
dri
hydrogen
bond
donor
hbd
hydrogen
bond
acceptor
hba
shape
tip
probe
process
follow
discard
node
energi
default
cutoff
valu
favor
region
extract
produc
mif
use
amanda
algorithm
base
field
intens
node
mutual
nodenod
distanc
select
node
final
encod
mif
process
consist
larg
auto
cross
correl
clacc
algorithm
result
consist
variabl
compar
maximum
autoand
crosscorrel
macc
method
obtain
valu
use
gener
correlogram
plot
product
nodenod
energi
repres
distanc
node
select
variabl
use
build
model
use
partial
least
squar
pl
gener
model
check
qualiti
point
view
intern
cross
valid
method
fraction
factori
design
ffd
method
employ
extract
relev
variabl
compound
activ
ffd
select
repeat
sever
time
model
improv
statist
paramet
r
q
sdep
valu
observ
model
valid
randomli
divid
origin
data
set
train
compound
receptor
respect
test
set
compound
receptor
base
activ
use
spss
version
train
set
compound
use
construct
predict
model
order
predict
test
compound
activ
identifi
outlier
gener
principl
compon
analysi
pca
compound
model
use
defin
applic
domain
method
roy
cowork
name
ad
use
standard
approach
version
pca
valu
x
variabl
variabl
biolog
activ
studi
compound
valid
final
model
evalu
use
intern
extern
crossvalid
method
intern
valid
leaveoneout
loo
leavetwoout
lto
method
use
predict
model
also
assess
calcul
standard
deviat
error
predict
sdep
mean
absolut
error
mae
base
criteria
use
extern
valid
plu
version
packag
pubchem
databas
chemic
molecul
search
base
structur
similar
core
structur
fig
deriv
studi
molecul
search
result
compound
compound
discard
base
appli
rule
five
criteria
implement
pubchem
web
server
structur
remain
compound
retriev
pubchem
dock
receptor
activ
predict
use
propos
model
physicchem
properti
molecul
calcul
use
hyperchem
version
profileprofil
align
perform
use
clustalw
program
implement
clustalx
version
energi
minim
bind
free
energi
calcul
carri
use
amber
suit
program
forc
field
version
oper
linuxbas
centu
gpu
work
station
best
pose
ligand
obtain
dock
calcul
use
md
simul
ligand
input
file
md
simul
gener
use
antechamb
packag
design
use
gener
amber
forc
field
gaff
order
prepar
receptorligand
complex
lipid
membran
environ
charmm
forc
field
avail
charmmgui
webbas
platform
charmmguiorg
employ
complex
embed
hydrat
preequilibr
dopc
lipid
bilay
dopc
molecul
per
complex
system
neutral
addit
potassium
chlorid
ion
final
concentr
mm
convert
tleap
readabl
file
use
script
subsequ
produc
file
introduc
tleap
program
forc
field
implement
ambertool
recruit
gener
amber
topolog
initi
coordin
file
gener
system
submit
short
energi
minim
process
includ
step
steepest
descent
step
conjug
gradient
follow
ps
heat
step
k
k
nvt
k
k
npt
ensembl
kcal
mol
harmon
restrain
appli
protein
lipid
system
equilibr
npt
ensembl
k
control
langevin
thermostat
bar
pressur
ns
follow
gradual
remov
restraint
bond
length
involv
hydrogen
atom
constrain
use
shake
algorithm
final
product
dynam
simul
perform
ns
appli
particl
mesh
ewald
pme
method
period
boundari
condit
constraint
appli
protein
lipid
ligand
molecul
bind
energi
calcul
ligandereceptor
complex
use
molecular
mechan
poissonboltzmann
surfac
area
mmpbsa
molecular
mechan
gener
born
surfac
area
mmgbsa
algorithm
interact
energi
calcul
exclud
lipid
water
molecul
counter
ion
present
averag
valu
aim
studi
deriv
model
set
compound
scaffold
tabl
order
identifi
structur
featur
essenti
interact
compound
receptor
obtain
result
could
use
identifi
new
ligand
activ
receptor
databas
search
drug
design
studi
current
studi
crystal
structur
receptor
complex
antagonist
use
virtual
screen
identifi
agonist
elucid
gpcr
adopt
activ
inact
structur
upon
bind
either
agonist
antagonist
respect
structur
agonist
solv
experiment
therefor
antagonistbound
structur
use
current
studi
examin
differ
might
activ
inact
form
receptor
activ
inact
structur
close
relat
gpcr
investig
basic
local
align
tool
blast
employ
search
protein
data
bank
structur
known
homolog
gpcr
search
identifi
adenosin
receptor
bound
antagonist
pdb
code
one
closest
homologu
receptor
ident
coverag
evalu
matter
fact
structur
adenosin
receptor
could
use
templat
homolog
model
receptor
experiment
structur
two
structur
adenosin
receptor
cocrystal
agonist
ligand
pdb
id
assum
agonist
antagonist
bound
structur
receptor
repres
activ
inact
form
calcul
ca
rmsd
adenosin
activ
inact
form
reveal
similar
rmsd
valu
activ
structur
inact
structur
compar
differ
two
activ
structur
rmsd
valu
structur
adenosin
receptor
activ
inact
form
compar
fig
observ
ident
gpcr
known
structur
receptor
indic
viabil
use
antagonistbound
receptor
structur
purpos
current
studi
may
feasibl
distinguish
fine
structur
differ
activ
inact
form
receptor
md
simul
moreov
studi
semiflex
dock
procedur
util
dock
ligand
retriev
databas
structur
similar
search
swissmodel
autom
homolog
model
server
use
develop
structur
receptor
server
provid
sequenc
gener
model
well
correspond
qualiti
measur
gener
best
model
propos
swissmodel
built
base
receptor
structur
pdb
code
templat
similar
target
sequenc
rmsd
valu
templat
model
calcul
deepview
version
program
qualiti
model
structur
verifi
use
differ
method
outlin
procheck
molprob
program
show
residu
allow
region
qmean
zscore
report
model
swissmodel
server
although
valu
demonstr
moder
qualiti
built
model
take
account
belong
gpcr
famili
model
consid
accept
model
structur
experiment
structur
receptor
use
dock
studi
activ
conform
ligand
obtain
dock
compound
activ
site
receptor
use
gold
program
best
activ
conform
activ
compound
data
set
ie
compound
receptor
respect
select
base
dock
score
compound
dock
score
upon
dock
receptor
appli
tanimoto
similar
method
implement
shapeit
program
version
activ
conform
remain
compound
data
set
select
base
similar
gener
dock
solut
compound
select
conform
activ
compound
tabl
compound
select
conform
use
qsar
model
build
outlin
select
best
conform
ligand
compound
divid
train
test
set
randomli
base
biolog
activ
use
spss
program
version
effort
similar
rang
biolog
activ
set
train
compound
subject
pentacl
program
gener
grindbas
descriptor
use
build
model
ffd
variabl
select
perform
sever
time
gener
model
signific
chang
statist
indic
squar
correl
coeffici
r
cross
valid
correl
coeffici
q
sdep
observ
intern
predict
model
evalu
loo
lto
method
obtain
statist
shown
tabl
seen
tabl
r
acc
valu
standard
deviat
error
calcul
sdec
model
improv
increas
number
latent
variabl
reach
optimum
valu
five
latent
variabl
although
loo
lto
q
valu
ie
respect
model
lower
lv
overal
assess
intern
valid
predict
error
suggest
model
best
model
activ
predict
howev
case
model
model
gener
valid
best
predict
model
predict
ie
loo
lto
level
error
sdec
point
view
fig
illustr
distanc
depend
plot
pl
coeffici
select
variabl
analyz
model
develop
import
variabl
model
summar
tabl
seen
tabl
fig
model
share
drydri
tiptip
variabl
almost
equal
probeprob
distanc
dryo
variabl
uniqu
mif
pair
select
model
posit
neg
impact
biolog
activ
respect
seen
fig
variabl
connect
thiazolidin
ring
hydroxyl
moieti
end
structur
indic
presenc
hydrophob
region
exampl
thiazolidin
ring
compound
distanc
hydrogen
acceptor
group
ie
hydroxyl
group
compound
posit
influenc
biolog
activ
well
select
studi
compound
toward
receptor
hand
analyz
pl
coeffici
reveal
posit
impact
variabl
higher
compound
whose
select
toward
higher
compar
compound
least
select
compound
toward
receptor
anoth
select
induc
variabl
dryo
connect
hydrophob
region
ie
thiazolidin
ring
compound
hydrogen
donor
group
ie
ether
oxygen
compound
far
apart
advers
affect
receptor
agonist
activ
impact
variabl
lower
select
compound
compound
select
compound
rather
receptor
take
account
explan
seem
dryo
variabl
consid
receptor
selectivityintroduc
factor
studi
compound
extern
predict
base
model
statist
five
latent
variabl
lv
select
optimum
number
pl
compon
receptor
activ
predict
model
r
valu
extern
predict
sdep
valu
model
respect
indic
good
predict
power
develop
model
experiment
vs
predict
valu
present
tabl
fig
accord
organ
econom
cooper
develop
oecd
requir
defin
applic
domain
ad
develop
qsar
model
therefor
calcul
pc
valu
pl
analysi
studi
compound
biolog
activ
analyz
applic
domain
use
standard
approach
program
determin
possibl
outlier
train
test
set
result
indic
none
structur
outlier
evalu
robust
model
error
predict
valu
calcul
result
present
tabl
calcul
mean
absolut
error
predict
test
set
model
respect
error
valu
smaller
ie
train
set
activ
rang
model
data
set
respect
indic
adequ
predict
abil
model
use
rigor
treatment
predict
maebas
tabl
dock
score
tanimoto
index
studi
compound
upon
dock
ligand
receptor
shapeit
program
use
select
conform
ligand
structur
similar
activ
compound
gold
score
tanimoto
index
valu
includ
comparison
shapeit
selecton
tabl
statist
data
built
pl
model
agonist
abbrevi
sdec
standard
deviat
error
calcul
sdep
standard
deviat
error
predict
acc
stand
accumul
valu
valid
method
use
calcul
q
leav
one
loo
leav
two
lto
random
five
group
order
propos
potenti
receptor
select
agonist
pubchem
databas
chemic
molecul
search
base
structur
similar
core
structur
studi
compound
fig
molecul
identifi
similar
search
structur
dock
bind
site
receptor
agonist
activ
best
dock
pose
identifi
molecul
predict
base
develop
model
result
demonstr
compound
pubchem
id
pubchem
id
pubchem
id
pubchem
id
could
bind
receptor
predict
ec
valu
nm
respect
predict
affin
toward
receptor
estim
consider
low
tabl
compar
predict
affin
toward
receptor
show
excel
select
compound
ec
ec
level
predict
select
compar
select
report
agonist
clinic
trial
ozanimod
siponimod
much
greater
compound
indic
compound
noteworthi
evalu
experi
develop
potent
select
agonist
moreov
among
select
compound
compound
show
high
predict
ec
valu
nm
accept
select
time
demonstr
feasibl
explor
potent
select
agonist
overal
seem
select
compound
pubchem
search
consid
promis
select
potent
receptor
agonist
experiment
vs
predict
ec
valu
compound
form
data
set
compound
use
train
set
model
respect
compound
test
set
open
fill
squar
indic
train
test
set
compound
respect
illustr
obtain
best
dock
pose
compound
complex
receptor
shown
fig
compar
receptor
cocrystal
antagonist
seen
fig
compound
data
set
interact
differ
receptor
compar
receptor
cocrystal
antagonist
compound
identifi
pubchem
search
howev
latter
compound
bind
site
antagonist
may
indic
capabl
receptor
recognit
analyz
chemic
structur
select
compound
reveal
import
detail
observ
result
term
predict
potenc
select
structur
tabl
summar
physicchem
properti
select
compound
comparison
compound
ozanimod
siponimod
analysi
show
compound
hydrophob
compound
higher
predict
activ
may
attribut
easi
penetr
lipophil
compound
innermost
bind
site
receptor
fig
effort
identifi
interact
mode
agonist
receptor
illustr
bind
gener
use
discoveri
studio
visual
version
program
fig
result
reveal
bind
compound
receptor
dominantli
stabil
hydrophob
interact
site
direct
mutat
studi
reveal
import
arg
glu
residu
locat
extracellular
end
third
transmembran
helix
tabl
structur
predict
activ
compound
select
pubchem
searcha
agonist
databas
chemic
molecul
pubchem
search
base
similar
core
structur
origin
data
set
select
compound
activ
predict
gener
model
receptor
signal
transduct
gonzalezcabrera
et
al
show
ligand
interact
arg
glu
residu
interact
one
exert
agonist
activ
improv
specif
analysi
identifi
ligand
dock
bind
site
receptor
fig
reveal
interact
time
arg
glu
observ
agreement
select
agonist
activ
predict
identifi
compound
obtain
databas
search
moreov
identifi
compound
also
interact
phe
trp
residu
known
essenti
agonist
activ
confirm
point
mutagenesi
studi
ligand
interact
leu
met
bind
site
selectivityinduc
residu
receptor
respect
identif
select
receptor
agonist
demonstr
previou
section
outlin
potenti
select
predict
base
mention
qualit
descript
bind
mode
receptor
defin
implicitli
develop
model
fig
although
conclus
one
may
state
bind
site
avail
receptor
e
protein
compound
could
share
similar
environ
receptor
bind
energi
ligand
order
calcul
free
bind
energi
compound
identifi
pubchem
search
complex
receptor
md
simul
perform
use
forc
field
avail
amber
receptor
dock
ligand
embed
lipid
bilay
membran
fig
md
simul
ns
tabl
repres
calcul
bind
energi
ligandsreceptor
interact
use
mmgbsa
mmpbsa
algorithm
ns
md
simul
result
reveal
compound
bind
receptor
stronger
rest
studi
compound
bind
dg
valu
kcal
mol
calcul
mmgbsa
mmpbsa
algorithm
respect
md
simul
compound
use
comparison
show
lowest
affin
toward
receptor
dg
bind
energi
valu
kcal
mol
calcul
mmgbsa
mmpbsa
algorithm
respect
interestingli
receptor
bind
energi
dg
valu
studi
compound
tabl
correl
strongli
predict
ec
valu
tabl
calcul
model
turn
valid
develop
model
current
work
aim
build
predict
model
seri
receptor
agonist
order
identifi
structur
featur
requir
design
receptor
select
agonist
valid
develop
model
evalu
intern
extern
cross
valid
method
gener
model
show
adequ
statist
paramet
predict
abil
result
show
interact
dryo
promot
agonist
activ
toward
receptor
furthermor
structur
variabl
associ
hydrophob
moieti
import
featur
influenc
receptor
select
studi
compound
structur
similar
search
pubchem
databas
use
core
structur
data
set
queri
structur
identifi
compound
compound
demonstr
excel
predict
potenc
select
toward
receptor
dock
potent
compound
ie
compound
data
set
identifi
databas
similar
search
show
interact
differ
receptor
may
attribut
higher
lipophil
identifi
compound
compar
compound
data
set
identifi
select
compound
similar
search
bind
e
protein
human
coronaviru
may
share
common
receptor
term
bind
site
provid
evid
agreement
result
obtain
model
moreov
receptor
bind
energi
calcul
use
molecular
dynam
simul
agonist
identifi
pubchem
databas
search
result
indic
appropri
receptor
affin
due
neg
bind
energi
also
close
agreement
predict
ec
valu
fig
receptor
complex
ligand
seen
compound
shown
green
stick
interact
differ
receptor
compar
receptor
cocrystal
antagonist
yellow
compound
pink
orang
cyan
purpl
pymol
program
version
use
gener
imag
interpret
refer
color
figur
legend
reader
refer
web
version
articl
fig
align
profil
prepar
receptor
e
protein
use
known
secondari
structur
inform
profil
gener
use
close
relat
sequenc
extract
ncbi
seen
e
protein
align
transmembran
helix
receptor
align
perform
use
clustalw
program
implement
clustalx
version
result
work
use
design
novel
potent
select
receptor
agonist
author
declar
conflict
interest
